![](/img/cover-not-exists.png)
412 POSTER An open-label study to characterize the pharmacokinetic (pk) parameters of erlotinib in patients with advanced solid tumors with adequate or moderately imparied hepatic function
C. O'Bryant, S. Eckhardt, S. Hariharan, S. Leong, C. Belani, R. Ramanathan, R. Boinpally, A. Gibbs, K. Wit, S. RamalingamVolume:
4
Year:
2006
Language:
english
DOI:
10.1016/s1359-6349(06)70417-7
File:
PDF, 72 KB
english, 2006